[1]
Yang G, Lu X, Yuan L. LncRNA: A link between RNA and cancer. Biochim Biophys Acta 2014; 1839(11): 1097-109.
[2]
Volders PJ, Helsens K, Wang X, et al. LNCipedia: a database for annotated human lncRNA transcript sequences and structures. Nucleic Acids Res 2013; 41(Database issue): D246-51.
[3]
Fridman WH, Pagès F, Sautès-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer 2012; 12(4): 298-306.
[4]
Fridman WH, Dieu-Nosjean MC, Pagès F, et al. The Immune Microenvironment of Human Tumors: General Significance and Clinical Impact. Cancer Microenviron 2012; 6(2): 117-22.
[5]
Sakaguchi S, Yamaguchi T, Nomura T, Ono M, Regulatory T. Cells and Immune Tolerance. Cell 2008; 133(5): 775-87.
[6]
Auffray C, Sieweke MH, Geissmann F. Blood Monocytes: Development, Heterogeneity, and Relationship with Dendritic Cells. Annu Rev Immunol 2009; 27(1): 669-92.
Current Bioinformatics
Title:LncRNA in Tumorigenesis Microenvironment
Volume: 14 Issue: 7
Author(s): Jie Ji, Kai-jian Xia, Junwei Tang and Runqiu Jiang
Affiliation:
Export Options
About this article
Cite this article as:
Ji Jie , Xia Kai-jian , Tang Junwei and Jiang Runqiu , LncRNA in Tumorigenesis Microenvironment, Current Bioinformatics 2019; 14 (7) . https://dx.doi.org/10.2174/157489361407190917161654
DOI https://dx.doi.org/10.2174/157489361407190917161654 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
16
2
1
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Iron Chelators for the Treatment of Cancer
Current Medicinal Chemistry Herpes Simplex Viruses in Antiviral Drug Discovery
Current Pharmaceutical Design Investigation of the Pharmacokinetics of the ABCG2 Transporter Inhibitor Ko134 in Mice by a Newly Developed and Validated HPLC Method
Current Pharmaceutical Analysis NMR-based Metabolite Profiling of Pancreatic Cancer
Current Metabolomics Plasminogen Activator Inhibitor-1 in Tumor Growth, Angiogenesis and Vascular Remodeling
Current Pharmaceutical Design Improvement of Adoptive Cellular Immunotherapy of Human Cancer Using Ex-Vivo Gene Transfer
Current Gene Therapy Targeting the Immune System in Cancer
Current Pharmaceutical Biotechnology A Comprehensive Review on the Genetic Regulation of Cisplatin-induced Nephrotoxicity
Current Genomics Immunosuppressive Therapy for Myelodysplastic Syndromes
Current Pharmaceutical Design Cytokines as Novel Therapeutic Agents for Neuroinflammatory Disorders: A Role for Interferon-β in the Treatment of Multiple Sclerosis
Current Medicinal Chemistry - Central Nervous System Agents Advances in Exploring the Role of Micrornas in Inflammatory Bowel Disease
MicroRNA Targeting ABCB1 and ABCC1 with their Specific Inhibitor CBT-1<sup>®</sup> can Overcome Drug Resistance in Osteosarcoma
Current Cancer Drug Targets Carbohydrate Antigens: Synthesis Aspects and Immunological Applications in Cancer
Mini-Reviews in Medicinal Chemistry D-Galactose as a Vector for Prodrug Design
Current Topics in Medicinal Chemistry Mapping the High Throughput SEREX Technology Screening for Novel Tumor Antigens
Combinatorial Chemistry & High Throughput Screening Nitric Oxide and Dietary Factors: Part III Minerals, Vitamins and Other Dietary and Lifestyle Factors
Vascular Disease Prevention (Discontinued) Hypoxia-Inducible Factors and Sphingosine 1-Phosphate Signaling
Anti-Cancer Agents in Medicinal Chemistry P-gp Inhibition-Based Strategies for Modulating Pharmacokinetics of Anticancer Drugs: An Update
Current Drug Metabolism Absorption, Disposition and Pharmacokinetics of Nanoemulsions
Current Drug Metabolism Ocular Toxicities in Cancer Therapy: Still Overlooked
Current Cancer Therapy Reviews